Cilostazol

Product NDC: 68151-3844
11-digit product format: 681513844
Labeler code: 68151
Product ID: 68151-3844_211b3b29-35eb-460c-962b-eba72c1b070a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cilostazol
Dosage form: TABLET
Route: ORAL
Labeler: Carilion Materials Management
Application: ANDA077024
Marketing category: ANDA
Marketing start: 2005-05-17
Marketing end: 0000-00-00
Substance: CILOSTAZOL
Active strength: 50 mg/1
Pharmacologic classes: Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68151-3844		I	Inactivated by FDA		2026-08-03
excluded package	package	68151-3844	68151-3844-2	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68151-3844-2	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68151-3844-2	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68151-3844-2	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68151-3844-2	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68151-3844-2	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68151-3844-2	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68151-3844-2	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68151-3844-2	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68151-3844-2	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68151-3844-2	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68151-3844-2	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68151-3844-2	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68151-3844-2	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68151-3844-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68151-3844-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68151-3844-2	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68151-3844-2	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68151-3844-2	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	68151-3844-2	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	68151-3844-2	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68151-3844-2	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	68151-3844-2	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077024-001	CILOSTAZOL	CILOSTAZOL	50MG	TABLET / ORAL			2005-05-17
A077024-002	CILOSTAZOL	CILOSTAZOL	100MG	TABLET / ORAL			2005-05-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL		2005-05-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL		2005-05-17	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077024-001	CILOSTAZOL	50MG	TABLET / ORAL	AB	2005-05-17	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077024-002	CILOSTAZOL	100MG	TABLET / ORAL	AB	2005-05-17	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077024-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077024-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077024-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077024-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077024-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077024-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077024-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077024-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077024-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A077024-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A077024-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077024-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A077024-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A077024-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A077024-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A077024-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A077024-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A077024-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A077024-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A077024-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A077024-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A077024-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A077024-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A077024-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A077024-002	AB	1	`ea99ee380514…`
2022-10-28 04:53 UTC	2022-10	A077024-001	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	A077024-002	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A077024-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	A077024-002	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077024-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A077024-002	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c114def4-591e-cde9-1a9f-29af28d4c1ea	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68151-3844-2	2020-01-31	C162847	48780-1	9d75b9d0-4c57-f424-e053-dadaa90a57ce	These highlights do not include all the information needed to use CILOSTAZOL TABLETS safely and effectively. See full prescribing information for CILOSTAZOL TABLETS. CILOSTAZOL tablets, for oral use Initial U.S. Approval: 1999

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68151-3844-2	Cilostazol	1 in 1 PACKAGE	TABLET	1		3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CILOSTAZOL	ACTIVE INGREDIENT	N7Z035406B	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
CILOSTAZOL	ACTIVE MOIETY	N7Z035406B	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68151-3844	CILOSTAZOL TABLET [CARILION MATERIALS MANAGEMENT]	3	Legacy NDC, 1 package rows	20160806_eb510ad0-dce7-4714-afc6-7959a151ad28.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
N7Z035406B	CILOSTAZOL	73963-72-1	CILOSTAZOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
242462	cilostazol 50 MG Oral Tablet	PSN	eb510ad0-dce7-4714-afc6-7959a151ad28	3
242462	cilostazol 50 MG Oral Tablet	SCD	eb510ad0-dce7-4714-afc6-7959a151ad28	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68151-3844-2	68151384402	1 in 1 PACKAGE	Historical